FHRX First Horizon Pharmaceutical (MM)

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the fourth quarter and year ended December 31, 2005, after the market closes on Thursday, February 23, 2006. Conference Call First Horizon will also host a conference call on Thursday, February 23, 2006, beginning at 5:00 p.m. Eastern time to discuss the financial results and update guidance for 2006. Analysts, investors and other interested parties are invited to participate by visiting the Company's website, http://www.fhrx.com, and entering the Investor Relations page. You may also dial in to the conference call. The dial-in numbers are (800) 289-0496 for domestic callers and (913) 981-5519 for international callers. All callers should use passcode 3492629 to gain access to the conference call. Please plan to dial-in or log on at least ten minutes prior to the designated start time so management can begin promptly. Replay A seven-day telephonic replay of this conference call will be available by dialing (888) 203-1112 for domestic callers and (719) 457-0820 for international callers. Callers should use the passcode 3492629 to gain access to the replay, which will be available through the end of the day on March 2, 2006. The replay will be available on the Investor Relations page of the Company's website for seven days. First Horizon Background First Horizon Pharmaceutical Corporation is a specialty pharmaceutical company that markets, sells and develops prescription products with a primary focus on cardiology and women's health. First Horizon has a portfolio that includes 15 branded prescription products, of which eight are actively promoted to high-prescribing physicians through its recently expanded nationwide sales force of approximately 525 representatives. First Horizon's web site address is: www.fhrx.com. Please visit First Horizon's website for full prescribing information on First Horizon's products.